24 completed, 4 unknown, 3 withdrawn, 1 active not recruiting. 11 Phase 2, 8 Phase 1, 7 Not applicable, 6 Phase 3, 2 Phase 4.
Follow Cidofovir: new trials by email Literature Review of Cidofovir trials Research Report on Cidofovir
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT cidofovir, Brincidofovir - Adenovirus Infections | Phase 3 | Recruiting | SymBio Pharmaceuticals | 180 | 2026-03-17 | 2026-10-19 |
| Clinical Trial for Evaluating the Efficacy and Safety of Electrocoagulation vs Topic Sinecatechins vs Topic Cidofovir Within the Treatment to High-grade Anal Intraepithelial Neoplasia in HIV Homosexual Males electrocoagulation, cidofovir 1% topical ointment, sinecatechins 10% topical ointment - High-grade Anal Intraepithelial Neoplasia | Phase 3 | Completed | Hospital Universitari Vall d'Hebron Research Institute | 108 | 2020-09-18 | 2024-07-10 |
| Airway Intervention Registry (AIR): Recurrent Respiratory Papillomatosis (RRP) Microdebrider, Cold-steel surgery (forceps), Carbon dioxide laser - Recurrent Respiratory Papillomatosis, Human Papilloma Virus | Unknown | Newcastle-upon-Tyne Hospitals NHS Trust | 400 | 2018-04-01 | 2022-01-11 | |
| Trial on Efficacy and Safety of Pritelivir Tablets for Treatment of Acyclovir-resistant Mucocutaneous HSV (Herpes Simplex Virus) Infections in Immunocompromised Subjects Pritelivir, Investigator's choice - HSV Infection | Phase 3 | Completed | AiCuris Anti-infective Cures AG | 158 | 2017-05-08 | 2026-06-12 |
| Efficacy and Safety Study of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir Maribavir, Ganciclovir, Valganciclovir - Cytomegalovirus (CMV) | Phase 3 | Completed | Shire | 352 | 2016-12-22 | 2021-11-03 |
| Intralesional Cidofovir for the Treatment of Recalcitrant Warts in the Pediatric Immune-suppressed Population. Cidofovir - Warts | Phase 2 | Withdrawn | University of Minnesota | 2016-06-01 | 2017-07-02 | |
| Bevacizumab Versus Cidofovir for the Treatment of Recurrent Respiratory Papillomatosis Bevacizumab, Cidofovir, Placebo - Recurrent Respiratory Papillomatosis | Phase 2 | Unknown | Centro de Investigación en. Enfermedades Infecciosas, Mexico | 36 | 2014-12-01 | 2016-07-26 |
| A Prospective, With One Site, Open-label Not Controled Trial, for the Observation of Treatment With CIDOFOVIR 1%, 3 Nights Per Week, During 4 Weeks, of Anal Intraepithelial Neoplasia, High Level, in HIV+ Patients Cidofovir 1% cream's basis, 2gr, three times per week, during 4 weeks. - HIV | Not applicable | Completed | Fundacion SEIMC-GESIDA | 20 | 2013-09-01 | 2016-06-29 |
| Intravesical Cidofovir for Hemorrhagic Cystitis Cidofovir, Probenecid - Blood And Marrow Transplantation | Phase 1 | Completed | M.D. Anderson Cancer Center | 6 | 2013-09-01 | 2016-12-06 |
| A Prolongation of a Clinical Study to Evaluate the Efficacy of an Aqueous Gel Containing 2% (w/w) of Cidofovir, Directly Applied on the Cervix Exhibiting High Grade Squamous Intraepithelial Lesions. Cidofovir - High Grade Cervical Epithelial Neoplasia (CIN2+) | Phase 2 | Completed | Brugmann University Hospital | 36 | 2013-02-01 | 2016-11-30 |
| Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia | Completed | Daniel Benjamin | 3520 | 2011-11-01 | 2023-09-06 | |
| Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis Cidofovir, No Cidofovir - Transplantation Infection | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 27 | 2011-03-17 | 2026-09-18 |
| Trial of Topical Cidofovir for the Prevention of Hair Growth 1% topical cidofovir, 3% topical cidofovir, Placebo - Prevention of Hair Growth | Phase 2 | Completed | University of Pennsylvania | 20 | 2009-07-01 | 2012-03-19 |
| Cidofovir in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer Who Are Receiving Chemotherapy and Radiation Therapy carboplatin, cidofovir, protein expression analysis - Cervical Cancer, Precancerous Condition | Phase 1 | Unknown | Gustave Roussy, Cancer Campus, Grand Paris | 24 | 2008-04-01 | 2010-01-28 |
| Modulation of the Expression of Papillomavirus (HPV) Oncoproteins to Major the Radiosensitivity: Trial Combining an Antiviral Agent VISTIDE and Radiochemotherapy in Cervical Cancers External radiotherapy + curietherapy, Vistide, Carboplatin - Cervical Cancer | Phase 1 | Completed | Gustave Roussy, Cancer Campus, Grand Paris | 15 | 2008-01-01 | 2026-08-13 |
| Cidofovir in Treating HIV-Infected Patients With High-Grade Squamous Intraepithelial Lesions of the Skin Near the Anus cidofovir, DNA methylation analysis, gene expression analysis - Anal Cancer, Precancerous Condition | Phase 2 | Completed | AIDS Malignancy Consortium | 33 | 2007-09-01 | 2015-12-21 |
| Cidofovir in Renal Transplant Recipients With BKVN Cidofovir, Placebo - BK Virus (Nephropathy) | Phase 1 / Phase 2 | Terminated | National Institute of Allergy and Infectious Diseases (NIAID) | 22 | 2006-05-01 | 2013-03-08 |
| Use of Cidofovir for Recurrent Respiratory Papillomatosis Cidofovir, Placebo - Recurrent Respiratory Papillomatosis | Phase 4 | Completed | University of Wisconsin, Madison | 19 | 1999-11-01 | 2019-02-26 |
| Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) Ganciclovir implant and oral ganciclovir, Cidofovir intravenous - Cytomegalovirus Retinitis, HIV Infections | Phase 3 | Completed | Johns Hopkins Bloomberg School of Public Health | 61 | 1997-05-01 | 2016-03-14 |
| Antiviral Therapy in Treating Patients With Kaposi's Sarcoma With or Without HIV Infection cidofovir - Sarcoma | Phase 2 | Completed | National Cancer Institute (NCI) | 1996-11-01 | 2013-06-20 |
Showing 20 of 34. Sign in to see all of them.
HIV Infections (12) · Cytomegalovirus Retinitis (10) · Acquired Immunodeficiency Syndrome (7) · Cytomegalovirus Infections (4) · Herpes Simplex (4) · Retinitis (4) · AIDS-Related Opportunistic Infections (3) · Adenoviridae Infections (3) · Cystitis, Hemorrhagic (3) · Recurrent respiratory papillomatosis (3) · Cystitis (2) · Pain (2) · Precancerous Conditions (2) · Squamous Intraepithelial Lesions (2) · Uterine Cervical Neoplasms (2)
Gilead Sciences (6) · National Institute of Allergy and Infectious Diseases (NIAID) (6) · M.D. Anderson Cancer Center (3) · Gustave Roussy, Cancer Campus, Grand Paris (2) · Johns Hopkins Bloomberg School of Public Health (2) · AIDS Malignancy Consortium (1) · AiCuris Anti-infective Cures AG (1) · Brugmann University Hospital (1) · Centro de Investigación en. Enfermedades Infecciosas, Mexico (1) · Daniel Benjamin (1) · Fundacion SEIMC-GESIDA (1) · Hospital Universitari Vall d'Hebron Research Institute (1) · National Cancer Institute (NCI) (1) · National Center for Research Resources (NCRR) (1) · Newcastle-upon-Tyne Hospitals NHS Trust (1)
United States (21) · United Kingdom (6) · Canada (5) · France (5) · Belgium (4) · Spain (4) · Germany (3) · Italy (3) · Australia (2) · Austria (2) · Denmark (2) · Israel (2) · Mexico (2) · Singapore (2) · Switzerland (2)
Douglas Jabs, MD (2) · Roy F. Chemaly, MD, MPH, MBA (2) · Adam Donne (1) · Barker DE (1) · Borje S. Andersson, MD,PHD (1) · Catherine Vanpachterbeke, MD (1) · Chi Hornik, PharmD (1) · Dankner W (1) · David V. Weinberg (1) · Elena Sendagorta, MD (1) · Elizabeth Stier, MD (1) · Eric Deutsch, MD (1) · Ingrid Polcari, MD (1) · J. Scott McMurray, MD (1)
PMID 18700421, PMID 21692673, PMID 23032420, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26612873, PMID 26731755, PMID 26926644, PMID 27016411, PMID 27522443, PMID 28137820, PMID 28290120, PMID 28779462, PMID 29084742, PMID 29271816, PMID 29435949, PMID 29677389, PMID 30790601, PMID 31042791, PMID 31317556, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33811823, PMID 33903114, PMID 34302290, PMID 34864943, PMID 35370711, PMID 35397828, PMID 35491971, PMID 37506264, PMID 38071422, PMID 39445512, PMID 39613120, PMID 40036375, PMID 40478680, PMID 41247430, PMID 41384277
2015 (1), U01CA121947 (1)